CREB5 has also been noted to serve as an integration site for xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer tissue from patients homozygous for a reduced activity variant of the antiviral enzyme RNase L [92]. The gene discussed is CREB5; the disease is Familial prostate cancer.